Xin Lang Cai Jing·2026-01-05 20:08Core Viewpoint - Spring Medical experienced a slight decline in stock price on December 31, with a trading volume of 24.47 million yuan, indicating a potential shift in investor sentiment and market dynamics [1] Financing Summary - On December 31, Spring Medical had a financing buy-in amount of 1.23 million yuan and a financing repayment of 1.39 million yuan, resulting in a net financing outflow of 0.15 million yuan [1] - The total financing and securities lending balance for Spring Medical reached 38.24 million yuan, with the financing balance accounting for 0.58% of the circulating market value, which is above the 70th percentile level over the past year, indicating a relatively high position [1] - The securities lending aspect showed no shares were repaid or sold on December 31, with a remaining securities lending volume of 200 shares and a balance of 4,576 yuan, also exceeding the 80th percentile level over the past year [1] Company Overview - Beijing Spring Medical Equipment Co., Ltd. was established on February 12, 1998, and went public on December 30, 2021, focusing on the research, production, and sales of implantable orthopedic medical devices [2] - The company's main products include joint prosthetics and spinal implant products, covering major human joints such as hip, knee, shoulder, and elbow, with a comprehensive range of spinal fixation systems [2] - As of September 30, Spring Medical reported a revenue of 756 million yuan for the first nine months of 2025, representing a year-on-year growth of 48.75%, and a net profit attributable to shareholders of 192 million yuan, reflecting a significant increase of 213.21% [2] Dividend and Shareholder Information - Since its A-share listing, Spring Medical has distributed a total of 440 million yuan in dividends, with 390 million yuan distributed over the past three years [3] - As of September 30, 2025, the number of shareholders increased by 4.12% to 6,164, while the average circulating shares per person decreased by 3.95% to 46,906 shares [2][3] - Notable institutional shareholders include Hong Kong Central Clearing Limited as the fourth largest shareholder with 2.96 million shares, and new entrants like China Europe Economic Growth Mixed A Fund and Ping An Low Carbon Economy Mixed A Fund [3]